Ionis Pharmaceuticals Inc (IONS)
33.94
-1.46
(-4.11%)
USD |
NASDAQ |
Nov 21, 16:00
33.94
0.00 (0.00%)
After-Hours: 17:24
Ionis Pharmaceuticals Market Cap: 5.360B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.590B |
| November 19, 2024 | 5.329B |
| November 18, 2024 | 5.326B |
| November 15, 2024 | 5.422B |
| November 14, 2024 | 5.879B |
| November 13, 2024 | 5.965B |
| November 12, 2024 | 5.964B |
| November 11, 2024 | 6.139B |
| November 08, 2024 | 6.188B |
| November 07, 2024 | 6.073B |
| November 06, 2024 | 6.164B |
| November 05, 2024 | 6.126B |
| November 04, 2024 | 6.070B |
| November 01, 2024 | 6.120B |
| October 31, 2024 | 6.062B |
| October 30, 2024 | 6.196B |
| October 29, 2024 | 6.267B |
| October 28, 2024 | 6.369B |
| October 25, 2024 | 6.185B |
| October 24, 2024 | 6.118B |
| October 23, 2024 | 6.063B |
| October 22, 2024 | 6.104B |
| October 21, 2024 | 6.155B |
| October 18, 2024 | 6.262B |
| October 17, 2024 | 6.074B |
| Date | Value |
|---|---|
| October 16, 2024 | 6.180B |
| October 15, 2024 | 5.972B |
| October 14, 2024 | 6.096B |
| October 11, 2024 | 6.066B |
| October 10, 2024 | 5.989B |
| October 09, 2024 | 6.006B |
| October 08, 2024 | 5.965B |
| October 07, 2024 | 5.975B |
| October 04, 2024 | 5.983B |
| October 03, 2024 | 5.967B |
| October 02, 2024 | 6.215B |
| October 01, 2024 | 6.166B |
| September 30, 2024 | 6.322B |
| September 27, 2024 | 6.442B |
| September 26, 2024 | 6.482B |
| September 25, 2024 | 6.465B |
| September 24, 2024 | 6.466B |
| September 23, 2024 | 6.597B |
| September 20, 2024 | 6.744B |
| September 19, 2024 | 6.741B |
| September 18, 2024 | 6.681B |
| September 17, 2024 | 6.547B |
| September 16, 2024 | 6.419B |
| September 13, 2024 | 6.654B |
| September 12, 2024 | 6.469B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.616B
Minimum
Dec 01 2021
9.181B
Maximum
Dec 16 2019
6.296B
Average
6.138B
Median
Sep 02 2022
Market Cap Benchmarks
| Biogen Inc | 23.00B |
| Alnylam Pharmaceuticals Inc | 31.84B |
| Biomarin Pharmaceutical Inc | 12.09B |
| Amicus Therapeutics Inc | 2.834B |
| Arbutus Biopharma Corp | 655.64M |
Market Cap Related Metrics
| PS Ratio | 6.168 |
| Price to Book Value | 8.091 |
| Price | 33.94 |
| Earnings Yield | -7.19% |